Precision Business Insights has published a report on the global canine oral chewable tablets market, estimating its value at USD 3.3 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 5.42% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/global-canine-oral-chewable-tablets-market
The canine oral chewable tablets market refers to the industry focused on chewable tablets designed for dogs, primarily for health and wellness purposes. These tablets serve various functions, including nutritional supplements, dental care, behavioural aids, and veterinary prescriptions
Drivers:
- Increasing Pet Ownership & Humanization of Pets: More pet owners treat their dogs as family members, leading to higher spending on health products
- Growing Awareness of Pet Health: Rising concerns about canine wellness drive demand for chewable tablets targeting dental care, joint health, digestive health, and anxiety relief
The global canine oral chewable tablets market segmentation:
- By Composition Type: Botanically synthesized, chemically synthesized
- By Drug Class: Analgesics, Anti-infective, Anti-ulcers, Vitamins & minerals, Cardiovascular drugs, Others
- By Application: Gastrointestinal diseases, Cardiovascular disorders, Infectious diseases, Nutritional supplements, Others
- By Product Type: Prescription, Over the Counter (OTC)
- By Distribution Channel: Veterinary clinics, Veterinary Pharmacies, Online veterinary stores, Others
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=16676
Regional Overview:
The report also examines the current concerns and their Future Effects on the canine oral chewable tablets market by the region. The report covers all regions and countries; North America was the largest and Asia was the fastest-growing region in the canine oral chewable tablets market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Zoetis, Inc. (Pfizer) (U.S.), Virbac AH Inc. (France), Elanco (Eli Lilly and Co.) (U.S.), Boehringer Ingelheim Vetmedica, Inc. (Boehringer Ingelheim) (Germany), Pala-Tech Laboratories (U.S.), Bayer HealthCare LLC (Bayer AG) (Germany), Merck Animal Health (Merck & Co. Inc.) (U.S.), Putney, Inc. (Dechra Pharmaceuticals) (U.K.)
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
